atenolol has been researched along with Koch's Disease in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, SV | 1 |
| Hanson, D | 1 |
| Peloquin, CA | 1 |
1 other study available for atenolol and Koch's Disease
| Article | Year |
|---|---|
Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
Topics: Aged; Antibiotics, Antitubercular; Antihypertensive Agents; Atenolol; Drug Interactions; Humans; Mal | 2003 |